Modulation of Cortical Gamma Synchrony in Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 220 participants.

Also called NCT05830617

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 220 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05830617
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05830617. Randomized; single masking; primary purpose treatment. Start 2021-03-23 (actual); primary completion 2024-03-23 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Modulation of Cortical Gamma Synchrony in Stroke
Acronym
GAMMASTROKE
Condition
Stroke
Intervention (Device)
real tACS
Intervention (Device)
sham tACS
Lead sponsor
IRCCS San Camillo, Venezia, Italy (class: other)
Collaborator
Campus Bio-Medico University (class: other)

Record details

Record id
cardio:ct-nct05830617
Content hash
3898a21e9bb3ebfbf79085213d2566cd6dfce9398a440fadcbf010a94a0c9d29